Black Diamond Therapeutics (NASDAQ:BDTX) Upgraded by Wall Street Zen to “Buy” Rating
Wall Street Zen upgraded shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday morning. Other equities analysts have also recently issued research reports about the company. HC Wainwright raised their price target on Black Diamond Therapeutics from $11.00 […]
Wall Street Zen upgraded shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday morning. Other equities analysts have also recently issued research reports about the company. HC Wainwright raised their price target on Black Diamond Therapeutics from $11.00 […]
